Skip to main navigation
Skip to search
Skip to main content
Universitas Airlangga Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Impacts
Student theses
Search by expertise, name or affiliation
Head and Neck Surgery
Airlangga University
Faculty of Medicine
Overview
Fingerprint
Network
Profiles
(1)
Research output
(3)
Research output
Research output per year
2023
2023
2024
2025
2025
3
Article
Research output per year
Research output per year
3 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2025
The impact of concurrent diabetes mellitus and hypertension on hospital length of stay in patients with phlegmon: A cross-sectional study at rsud dr. soetomo surabaya
Putra, D. A.,
Wibowo, M. D.
,
Susilo, D. H.
& Fandinata, S. S.,
Feb 2025
,
In:
Journal of Medicinal and Pharmaceutical Chemistry Research.
7
,
2
,
p. 150-160
11 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Surabaya
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Hypertension
100%
Length of Hospital Stay
100%
Phlegmon
100%
2024
A rare presentation of rhino-orbital-cutaneous mucormycosis in an immunocompetent patient: a case report
Dhiyantari, N. P. A. R.,
Lutfi, D.
,
Susilo, D. H.
,
Kristyono, I.
& Widya, A.,
1 May 2024
,
In:
Pan African Medical Journal.
48
, 13.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Immunocompromised Patients
100%
Rare Presentation
100%
Cutaneous mucormycosis
100%
Rhino-orbital
100%
Mucormycosis
100%
2023
The relationship between the difference neutrophto lymphocyte ratio before and after anthracycline-based neoadjuvant chemotherapy with clinical response in locally advanced breast cancer
Rahman, H.,
Ali, I.
&
Susilo, D. H.
,
2023
,
In:
Bali Medical Journal.
12
,
3
,
p. 3088-3092
5 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Anthracyclines
100%
Lymphocyte Count
100%
Neutrophil-to-lymphocyte Ratio
100%
Clinical Response
100%
Locally Advanced Breast Cancer
100%